|
Volumn 62, Issue 3, 2000, Pages 125-130
|
A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE2 gel (meteneprost) or 600 μg oral PGE1 (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period
a a a a a a a a a a a a a a a a a a |
Author keywords
Comparative efficacy; Early termination; Meteneprost; Mifepristone; Misoprostol; Successful outcome
|
Indexed keywords
METENEPROST;
MIFEPRISTONE;
MISOPROSTOL;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
BRONCHOSPASM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
FEMALE;
FEVER;
HUMAN;
HYPERTENSION;
INDUCED ABORTION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NAUSEA;
PREGNANCY TERMINATION;
RANDOMIZED CONTROLLED TRIAL;
RIGOR;
TREATMENT OUTCOME;
VERTIGO;
VOMITING;
16,16-DIMETHYLPROSTAGLANDIN E2;
ABORTIFACIENT AGENTS;
ABORTION, THERAPEUTIC;
ADOLESCENT;
ADULT;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MENSTRUAL CYCLE;
MIFEPRISTONE;
MISOPROSTOL;
OUTCOME ASSESSMENT (HEALTH CARE);
PREGNANCY;
|
EID: 0033634710
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-7824(00)00154-2 Document Type: Article |
Times cited : (10)
|
References (14)
|